XML 40 R10.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating activities      
Net income $ 345,000,000 $ 276,000,000 $ 309,000,000
Adjustments to reconcile net income to net cash flows provided by operating activities:      
Depreciation and amortization 172,000,000 154,000,000 135,000,000
Goodwill impairment 0 37,000,000 0
Gains on divestitures (24,000,000) (2,000,000) 0
Stock-based compensation 23,000,000 0 0
Losses on foreign exchange transactions 11,000,000 4,000,000 18,000,000
Losses (gains) on investments, net 6,000,000 (6,000,000) (18,000,000)
Deferred income taxes (6,000,000) 11,000,000 10,000,000
Settlement losses 0 0 18,000,000
Other, net 14,000,000 11,000,000 8,000,000
Changes in assets and liabilities, excluding the effects of acquisitions and divestitures:      
Accounts receivable (31,000,000) 6,000,000 (15,000,000)
Contract and other assets 3,000,000 (33,000,000) (12,000,000)
Accounts payable 13,000,000 1,000,000 (18,000,000)
Accrued expenses 7,000,000 (28,000,000) (85,000,000)
Pension and postretirement benefit plans (9,000,000) 4,000,000 19,000,000
Contract and other liabilities 0 32,000,000 3,000,000
Net cash flows provided by operating activities 524,000,000 467,000,000 372,000,000
Investing activities      
Capital expenditures (237,000,000) (215,000,000) (164,000,000)
Acquisitions, net of cash acquired (26,000,000) (18,000,000) (66,000,000)
Proceeds from divestitures 29,000,000 4,000,000 0
Sales of investments 0 144,000,000 155,000,000
Purchases of investments 0 (95,000,000) (162,000,000)
Other investing activities, net 0 5,000,000 (1,000,000)
Net cash flows used in investing activities (234,000,000) (175,000,000) (238,000,000)
Financing activities      
Proceeds from long-term debt 181,000,000 440,000,000 700,000,000
Repayments of long-term debt (346,000,000) (30,000,000) (200,000,000)
Dividends to stockholders of UL Solutions (100,000,000) (680,000,000) (1,600,000,000)
Dividends to non-controlling interest (15,000,000) (14,000,000) (13,000,000)
Other financing activities, net (4,000,000) (10,000,000) (3,000,000)
Net cash flows used in financing activities (284,000,000) (294,000,000) (1,116,000,000)
Effect of exchange rate changes on cash and cash equivalents (23,000,000) (5,000,000) (24,000,000)
Net decrease in cash and cash equivalents (17,000,000) (7,000,000) (1,006,000,000)
Cash and cash equivalents      
Beginning of period 315,000,000 322,000,000 1,328,000,000
End of period 298,000,000 315,000,000 322,000,000
Supplemental disclosures of cash flow information      
Cash paid during the period for interest 57,000,000 32,000,000 17,000,000
Cash paid during the period for income taxes 66,000,000 57,000,000 68,000,000
Cash paid during the period for stock-based compensation 19,000,000 61,000,000 48,000,000
Noncash investing and financing activities      
Capital expenditures funded by liabilities 43,000,000 46,000,000 29,000,000
Conversion of stock-based compensation awards to equity (Note 18) $ 26,000,000 $ 0 $ 0